Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback